ICVTS Click here for other ICVTS advertising opportunities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published on June 29, 2009, doi:10.1510/icvts.2008.200592

Interactive CardioVascular and Thoracic Surgery 2009;9:471.

This Article
Right arrow Full Text (Journal Format PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eComments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Makhija, Z.
Right arrow Articles by Desai, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makhija, Z.
Right arrow Articles by Desai, J.
Related Collections
Right arrow Valve disease

Valves

Early and mid-term functional and survival benefits in ischaemic versus degenerative mitral valve repair using Duran flexible ring: a single surgeon series

Zeena Makhija 1* Jatin Desai 1

1 Kings College Hospital, Denmark Hill, London, UK

* To whom correspondence should be addressed. E-mail: profknow171{at}yahoo.com.


   Abstract
The late results of ischaemic mitral valve (MV) repair have been less than satisfying. We compared echocardiographically, the changes in LV function, mid-term durability and survival between MV repair caused by ischaemic cardiomyopathy (n=60) with degenerative MV disease (n=73) over a period of 15 years. The duration of mean follow-up was 3.7±4.1 years in the ischaemic group and 3.9±2.9 years in the degenerative group. Freedom from reoperation at seven years was 98.3%±1.5% and 98.9%±2.1%, respectively (P=0.889). At the last follow-up, NYHA functional class I or II was present in 78.4% of patients in the ischaemic group and 80.9% patients in the degenerative group (P=0.347). An improvement in LVEF was noted in both the groups: ischaemic - 41.3±12.7 (pre-op LVEF: 38.8±14.1) and degenerative - 46.5±11.1 (pre-op LVEF: 45.7±11.7) (P=0.014). At seven years, freedom from a cardiac cause of death was statistically similar in the two groups: 93.3%±1.3% and 92.2%±0.6% (P=0.967). In conclusion, the mid-term results of ischaemic MV repair are similar to those obtained for degenerative MV repair. Surgical correction of ischaemic MR results in long-term improved LVEF and comparable outcomes in terms of freedom from reoperation and survival. Keywords: Ischaemic; Mitral valve; Repair





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 European Association for Cardio-thoracic Surgery